| Identifiers | |
|---|---|
|
|
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| ECHA InfoCard | 100.230.440 |
| Chemical and physical data | |
| Formula | C24H25ClN2O2 |
| Molar mass | 408.919 |
| 3D model (Jmol) | |
|
|
|
|
NPS-2143 (SB-262,470A) is a calcilytic drug which acts as an antagonist at the Calcium-sensing receptor (CaSR), and consequently stimulates release of parathyroid hormone. Calcilytic drugs have been researched as potential treatments for osteoporosis, and as the first such compound developed, NPS-2143 is still widely used in research into the CaSR receptor as well as design of newer calcilytic agents.